ACRV Acrivon Therapeutics, Inc. - Common Stock
$2,01
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 12, 2026
52 Haftlık Aralık
$1–$4
32% of range
Analist Derecelendirmesi
BUY
14 analysts
Fiyat Hedefi
$12
+474% upside
P/E (TTM)
-1.0
ROE
-61.0%
Net Kâr Marjı
—
ACRV Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$2.00
Piyasa Değeri
$63M
P/E (TTM)
-1.0
EPS (TTM)
$-2.02
Gelir (TTM)
—
Temettü Verimi
—
ROE
-61.0%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $4
ACRV Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-2.02
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-65M
2022-12-31
→
2025-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ACRV
Akran Ortalaması
P/E (TTM)
-1.0
4.7
P/B (F/D)
0.6
1.8
Price / FCF (Fiyat / Serbest Nakit Akışı)
-1.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ACRV
Akran Ortalaması
ROA
-47.8%
-68.1%
ROE
-61.0%
-111.7%
ROIC
-74.8%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ACRV
Akran Ortalaması
Current Ratio (Cari Oran)
7.7
4.1
Quick Ratio (Cari Oran)
7.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ACRV
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ACRV
Akran Ortalaması
ACRV Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
14 analist
- Güçlü Al 4 28,6%
- Al 9 64,3%
- Tut 1 7,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
6 analist · 2026-08-15
Medyan
$10.50
Ortalama
$11.50
← Tüm hedeflerin altında
$2.00
Düşük
$7.00
Yüksek
$19.00
Medyan hedef
$10.50
+423,7%
Ortalama hedef
$11.50
+473,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.07%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.49 | $-0.54 | 0.05% |
| 31 Aralık 2025 | $-0.52 | $-0.48 | -0.04% |
| 30 Eylül 2025 | $-0.47 | $-0.60 | 0.13% |
| 30 Haziran 2025 | $-0.55 | $-0.60 | 0.05% |
| 31 Mart 2025 | $-0.51 | $-0.66 | 0.15% |
| 31 Aralık 2024 | $-0.60 | $-0.68 | 0.08% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| FBIO | — | — | — | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| ACET | — | -0.5 | — | — | — | — |
| SERA | — | -4.4 | 5.2% | -39417.3% | -39.0% | — |
| ELTX | — | -3.1 | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $60M | $64M | $46M | $24M | · | |
| SG&A Expense | $24M | $25M | $21M | $9M | · | |
| Operating Expenses | $84M | $89M | $67M | $33M | $16M | |
| Operating Income | $-84M | $-89M | $-67M | $-33M | $-16M | |
| Interest Income | · | · | $7M | $2M | · | |
| Other Non-op | $-270.0K | $-558.0K | $-322.0K | $1M | $21.0K | |
| Pretax Income | $-78M | $-80M | · | · | · | |
| Income Tax | $0 | · | · | · | · | |
| Net Income | $-78M | $-81M | $-60M | $-31M | $-16M | |
| EPS (Basic) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| EPS (Diluted) | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 | |
| Shares (Basic) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| Shares (Diluted) | 38,509,281 | 33,791,817 | 22,078,190 | 4,121,912 | 1,743,382 | |
| EBITDA | $-84M | $-89M | $-67M | $-33M | · |
Bilanço 20
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $40M | $36M | $30M | $100M | |
| Short-term Investments | $77M | $140M | $91M | $98M | · | |
| Prepaid Expense | $2M | $2M | $2M | $4M | $805.0K | |
| Current Assets | $120M | $182M | $130M | $132M | $100M | |
| PP&E (Net) | $5M | $4M | $3M | $2M | $290.0K | |
| PP&E (Gross) | $8M | $6M | $4M | $3M | $346.0K | |
| Accum. Depreciation | $3M | $2M | $956.0K | $420.0K | $56.0K | |
| Other Non-current Assets | $2M | $2M | $251.0K | · | · | |
| Total Assets | $130M | $197M | $138M | $181M | $107M | |
| Accounts Payable | $2M | $758.0K | $5M | $904.0K | $964.0K | |
| Current Liabilities | $16M | $17M | $13M | $7M | $3M | |
| Capital Leases | $2M | $3M | $4M | $4M | $5M | |
| Total Liabilities | $17M | $20M | $17M | $11M | $8M | |
| Common Stock | $31.0K | $31.0K | $23.0K | $22.0K | $2.0K | |
| Paid-in Capital | $387M | $373M | $238M | $227M | $1M | |
| Retained Earnings | $-275M | $-197M | $-116M | $-56M | $-25M | |
| AOCI | $111.0K | $447.0K | $-83.0K | $-95.0K | · | |
| Stockholders' Equity | $113M | $177M | $121M | $170M | $-24M | |
| Liabilities + Equity | $130M | $197M | $138M | $181M | $107M | |
| Shares Outstanding | 31,648,856 | 31,231,264 | 22,522,644 | 21,920,402 | 1,769,561 |
Nakit Akışı 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $15M | $14M | $12M | $2M | $497.0K | |
| Operating Cash Flow | $-64M | $-66M | $-43M | $-30M | $-14M | |
| CapEx | $2M | $3M | $1M | $2M | $238.0K | |
| Investing Cash Flow | $66M | $-52M | $51M | $-142M | $-238.0K | |
| Financing Cash Flow | $-749.0K | $121M | $-2M | $102M | $112M | |
| Net Change in Cash | $2M | $4M | $7M | $-70M | $98M | |
| Free Cash Flow | $-65M | $-68M | $-44M | $-32M | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -47.8% | -48.1% | -37.8% | -21.7% | · | |
| ROE | -61.0% | -43.1% | -46.6% | -49.9% | · | |
| ROIC | -74.8% | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 10.6 | 9.7 | 20.3 | · | |
| Quick Ratio | 7.6 | 10.4 | 9.6 | 19.6 | · |
Değerleme (TTM) 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-81M | $-60M | $-31M | · | |
| Market Cap | $76M | $188M | $111M | $253M | · | |
| P/E | -1.2 | -2.5 | -1.8 | -1.5 | · | |
| P/B | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Tangible Book | 0.7 | 1.1 | 0.9 | 1.5 | · | |
| P / Cash Flow | -1.2 | -2.9 | -2.6 | -8.4 | · | |
| P / FCF | -1.2 | -2.7 | -2.5 | -7.8 | · | |
| Earnings Yield | -83.8% | -39.5% | -55.7% | -65.6% | · |
Gelir Tablosu 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $15M | $15M | $14M | $16M | $15M | $19M | $19M | $15M | $11M | $15M | $10M | $11M | $10M | · | · | |
| SG&A Expense | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | · | · | |
| Operating Expenses | $19M | $20M | $20M | $20M | $23M | $22M | $25M | $25M | $21M | $18M | $21M | $16M | $16M | $14M | $10M | $10M | |
| Operating Income | $-19M | $-20M | $-20M | $-20M | $-23M | $-22M | $-25M | $-25M | $-21M | $-18M | $-21M | $-16M | $-16M | $-14M | $-10M | $-10M | |
| Other Non-op | $-156.0K | $-129.0K | $-116.0K | $-53.0K | $-87.0K | $-14.0K | $-240.0K | $1.0K | $-55.0K | $-264.0K | $109.0K | $-97.0K | $-164.0K | $-170.0K | $1M | $377.0K | |
| Net Income | $-18M | $-19M | $-19M | $-18M | $-21M | $-20M | $-23M | $-22M | $-19M | $-16M | $-19M | $-14M | $-14M | $-13M | $-9M | $-9M | |
| EPS (Basic) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| EPS (Diluted) | $-0.43 | $-0.49 | $-0.49 | $-0.47 | $-0.55 | $-0.51 | $-0.54 | $-0.59 | $-0.52 | $-0.73 | $-0.87 | $-0.66 | $-0.63 | $-0.58 | $4.98 | $-5.17 | |
| Shares (Basic) | 41,841,887 | 38,724,803 | -76,863,246 | 38,560,464 | 38,461,619 | 38,350,444 | -63,036,734 | 38,105,131 | 36,132,616 | 22,590,804 | -43,894,574 | 22,081,162 | 21,971,032 | 21,920,570 | -1,195,465 | 1,778,255 | |
| Shares (Diluted) | 41,841,887 | 38,724,803 | -76,863,246 | 38,560,464 | 38,461,619 | 38,350,444 | -63,036,734 | 38,105,131 | 36,132,616 | 22,590,804 | -43,894,574 | 22,081,162 | 21,971,032 | 21,920,570 | -1,195,465 | 1,778,255 | |
| EBITDA | $-19M | $-20M | · | $-20M | $-23M | $-22M | · | $-25M | $-21M | $-18M | · | $-16M | $-16M | $-14M | · | $-10M |
Bilanço 20
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $34M | $41M | $35M | $42M | $39M | $40M | $43M | $46M | $25M | $36M | $30M | $38M | $27M | $30M | $32M | |
| Short-term Investments | $49M | $64M | $77M | $94M | $96M | $110M | $140M | $144M | $135M | $85M | $91M | $112M | $113M | $93M | $98M | · | |
| Prepaid Expense | $2M | $1M | $2M | $1M | $989.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $2M | |
| Current Assets | $91M | $99M | $120M | $130M | $138M | $151M | $182M | $189M | $182M | $112M | $130M | $144M | $153M | $124M | $132M | $79M | |
| PP&E (Net) | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $807.0K | $674.0K | $545.0K | $420.0K | $295.0K | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | $251.0K | · | · | · | · | · | |
| Total Assets | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Accounts Payable | $861.0K | $1M | $2M | $996.0K | $1M | $4M | $758.0K | $2M | $1M | $2M | $5M | $2M | $1M | $1M | $904.0K | $2M | |
| Current Liabilities | $11M | $11M | $16M | $15M | $13M | $14M | $17M | $15M | $11M | $9M | $13M | $9M | $7M | $6M | $7M | $6M | |
| Capital Leases | $980.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $12M | $12M | $17M | $17M | $16M | $16M | $20M | $18M | $15M | $13M | $17M | $13M | $11M | $10M | $11M | $11M | |
| Common Stock | $42.0K | $38.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $2.0K | |
| Paid-in Capital | $399M | $389M | $387M | $384M | $381M | $377M | $373M | $370M | $368M | $241M | $238M | $236M | $232M | $229M | $227M | $2M | |
| Retained Earnings | $-312M | $-294M | $-275M | $-256M | $-238M | $-217M | $-197M | $-174M | $-152M | $-133M | $-116M | $-97M | $-83M | $-69M | $-56M | $-47M | |
| AOCI | $-33.0K | $4.0K | $111.0K | $112.0K | $106.0K | $283.0K | $447.0K | $782.0K | $-19.0K | $-70.0K | $-83.0K | $-302.0K | $-427.0K | $9.0K | $-95.0K | $-133.0K | |
| Stockholders' Equity | $87M | $96M | $113M | $129M | $143M | $160M | $177M | $197M | $216M | $108M | $121M | $138M | $149M | $160M | $170M | $-46M | |
| Liabilities + Equity | $99M | $108M | $130M | $145M | $159M | $176M | $197M | $215M | $231M | $121M | $138M | $151M | $160M | $170M | $181M | $88M | |
| Shares Outstanding | 42,847,215 | 38,745,032 | 31,648,856 | 31,549,770 | 31,449,744 | 31,352,067 | 31,231,264 | 31,130,892 | 30,966,255 | 22,637,539 | 22,522,644 | 22,104,469 | 22,068,660 | 21,920,634 | 21,920,402 | 1,794,600 |
Nakit Akışı 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $267.0K | |
| Operating Cash Flow | $-15M | $-21M | $-15M | $-12M | $-17M | $-20M | $-17M | $-17M | $-14M | $-17M | $-12M | $-10M | $-9M | $-11M | $-9M | $-7M | |
| CapEx | $87.0K | $14.0K | $219.0K | $899.0K | $493.0K | $58.0K | $827.0K | $989.0K | $137.0K | $815.0K | $1M | $0 | $112.0K | $25.0K | $251.0K | $426.0K | |
| Investing Cash Flow | $15M | $13M | $22M | $6M | $19M | $19M | $14M | $16M | $-88M | $6M | $21M | $2M | $19M | $9M | $-95M | $-45M | |
| Financing Cash Flow | $7M | $-33.0K | $-192.0K | $-117.0K | $-97.0K | $-343.0K | $-647.0K | $-2M | $123M | $-172.0K | $-2M | $78.0K | · | · | $102M | $-140.0K | |
| Net Change in Cash | $7M | $-7M | $6M | $-6M | $3M | $-664.0K | $-4M | $-3M | $21M | $-11M | $6M | $-8M | $11M | $-2M | $-3M | $-52M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | $-18M | · | · | · | $-11M | · | · |
Kârlılık 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -13.9% | -13.4% | · | -10.1% | -10.8% | -13.3% | · | -12.3% | -9.6% | -11.3% | · | -12.1% | -17.4% | -15.0% | · | -21.0% | |
| ROE | -15.6% | -14.9% | · | -11.2% | -11.7% | -14.7% | · | -13.4% | -10.3% | -12.3% | · | -31.3% | -18.6% | -15.9% | · | 40.3% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.0 | · | 8.8 | 10.3 | 11.2 | · | 12.8 | 16.2 | 12.4 | · | 15.5 | 21.8 | 21.8 | · | 12.3 | |
| Quick Ratio | 7.9 | 8.8 | · | 8.7 | 10.2 | 11.0 | · | 12.6 | 16.0 | 12.2 | · | 15.3 | 21.5 | 21.2 | · | 5.0 |
Değerleme (TTM) 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-76M | $-78M | · | $-81M | $-82M | $-77M | · | $-72M | $-64M | $-58M | · | $-50M | $-42M | $-35M | · | $-25M | |
| Market Cap | $76M | $54M | · | $57M | $37M | $64M | · | $218M | $180M | $162M | · | $211M | $286M | $278M | · | · | |
| P/E | -0.9 | -0.7 | · | -0.9 | -0.5 | -0.9 | · | -2.8 | -2.3 | -2.8 | · | -1.4 | -1.3 | -1.0 | · | · | |
| P/B | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Tangible Book | 0.9 | 0.6 | · | 0.4 | 0.3 | 0.4 | · | 1.1 | 0.8 | 1.5 | · | 1.5 | 1.9 | 1.7 | · | · | |
| P / Cash Flow | · | -2.6 | · | · | · | -3.3 | · | · | · | -9.5 | · | · | · | -24.5 | · | · | |
| P / FCF | · | -2.6 | · | · | · | -3.2 | · | · | · | -9.0 | · | · | · | -24.4 | · | · | |
| Earnings Yield | -109.0% | -145.3% | · | -117.1% | -182.3% | -115.8% | · | -35.7% | -43.8% | -36.4% | · | -73.6% | -74.6% | -103.4% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Gelir | $-78M | $-81M | $-60M | $-31M | $-16M |
| Seyreltilmiş Hisse Başı Kâr | $-2.02 | $-2.38 | $-2.74 | $-7.56 | $-9.32 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 7.7 | 10.6 | 9.7 | 20.3 | — |
| Cari Oran | 7.6 | 10.4 | 9.6 | 19.6 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-65M | $-68M | $-44M | $-32M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 49 dosya · $36.5M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 8 (+1 önceki Ç'ye göre) | 3 (-9 önceki Ç'ye göre) | 15 (+6 önceki Ç'ye göre) | 7 (-3 önceki Ç'ye göre) | +6.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $21.768.325 | 12.229.396 | 59,72% | Hisse senetleri |
| Sands Capital Alternatives, LLC | $4.074.902 | 2.289.271 | 11,18% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.694.574 | 952.008 | 4,65% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $1.580.871 | 888.130 | 4,34% | Hisse senetleri |
| VANGUARD GROUP INC | $1.414.369 | 586.875 | 3,88% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.350.776 | 758.863 | 3,71% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.141.866 | 641.498 | 3,13% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $804.393 | 333.773 | 2,21% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $674.442 | 378.900 | 1,85% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $399.619 | 224.424 | 1,10% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $327.748 | 184.128 | 0,90% | Hisse senetleri |
| XTX Topco Ltd | $317.265 | 178.239 | 0,87% | Hisse senetleri |
| NORTHERN TRUST CORP | $119.620 | 67.202 | 0,33% | Hisse senetleri |
| STATE STREET CORP | $119.518 | 67.145 | 0,33% | Hisse senetleri |
| JANE STREET GROUP, LLC | $117.845 | 66.205 | 0,32% | Hisse senetleri |
| CITADEL ADVISORS LLC | $73.471 | 41.276 | 0,20% | Hisse senetleri |
| UBS Group AG | $65.335 | 36.705 | 0,18% | Hisse senetleri |
| MARSHALL WACE, LLP | $60.160 | 33.798 | 0,17% | Hisse senetleri |
| Spark Investment Management LLC | $50.374 | 28.300 | 0,14% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $42.747 | 24.015 | 0,12% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $29.204 | 16.407 | 0,08% | Hisse senetleri |
| Verdad Advisers, LP | $26.796 | 15.054 | 0,07% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $26.558 | 14.920 | 0,07% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $24.566 | 13.801 | 0,07% | Hisse senetleri |
| Squarepoint Ops LLC | $23.690 | 13.309 | 0,06% | Hisse senetleri |
| AAF Wealth Management, LLC | $19.007 | 10.678 | 0,05% | Hisse senetleri |
| BlackRock, Inc. | $18.873 | 10.603 | 0,05% | Hisse senetleri |
| Marex Group Ltd | $17.800 | 10.000 | 0,05% | Hisse senetleri |
| FEDERATED HERMES, INC. | $14.105 | 7.924 | 0,04% | Hisse senetleri |
| FMR LLC | $12.383 | 6.957 | 0,03% | Hisse senetleri |
| BARCLAYS PLC | $10.573 | 5.940 | 0,03% | Hisse senetleri |
| Nuveen Asset Management, LLC | $9.518 | 1.581 | 0,03% | Hisse senetleri |
| MORGAN STANLEY | $7.782 | 4.372 | 0,02% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $2.985 | 1.677 | 0,01% | Hisse senetleri |
| ACADIAN ASSET MANAGEMENT LLC | $2.073 | 1.165.119 | 0,01% | Hisse senetleri |
| Crews Bank & Trust | $1.858 | 1.044 | 0,01% | Hisse senetleri |
| NISA INVESTMENT ADVISORS, LLC | $1.040 | 584 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $956 | 537 | 0,00% | Hisse senetleri |
| Redwood Park Advisors LLC | $890 | 500 | 0,00% | Hisse senetleri |
| Russell Investments Group, Ltd. | $856 | 481 | 0,00% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $712 | 400 | 0,00% | Hisse senetleri |
| Steward Partners Investment Advisory, LLC | $580 | 326 | 0,00% | Hisse senetleri |
| GSA CAPITAL PARTNERS LLP | $357 | 200.415 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $164 | 92 | 0,00% | Hisse senetleri |
| SBI Securities Co., Ltd. | $134 | 75 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $89 | 50 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $18 | 10.316 | 0,00% | Hisse senetleri |
| CITIGROUP INC | $11 | 6 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 30 | 0,00% | Hisse senetleri |
Şirket yöneticileri 17 içeriden öğrenenler · 9 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Peter Blume-Jensen | President and CEO | 14 Ağustos 2024 F | 2.502.129 | 0 | 0 | $0 |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 01 Mart 2025 A | 26.088 | 0 | 0 | $0 |
| Eric Devroe | Chief Operating Officer | 18 Mayıs 2026 A | 146.953 | 1 | 0 | $17.200 |
| Mary Miller | Chief Legal Officer | 21 Temmuz 2026 S | 82.194 | 0 | 1 | $-1.008 |
| Katharine Peterson | Chief Accounting Officer | 18 Mayıs 2026 A | 18.134 | 0 | 0 | $0 |
| Erick Gamelin | Chief Development Officer | 18 Mayıs 2026 A | 52.992 | 0 | 0 | $0 |
| Mansoor Raza Mirza | Chief Medical Officer | 18 Mayıs 2026 A | 38.817 | 0 | 0 | $0 |
| Jean-Marie Cuillerot | Chief Medical Officer | 01 Mart 2025 A | — | 0 | 0 | $0 |
| Kristina Masson | EVP - Business Operations | 14 Ağustos 2024 F | 317.246 | 0 | 0 | $0 |
| Santhosh Palani | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Derek Dirocco | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Sharon Shacham | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Charles M Baum | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Michael John Tomsicek | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Yönetim kurulu üyesi | 17 Haziran 2026 A | 9.366 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% sahip | 17 Kasım 2022 C | 888.130 | 0 | 0 | $0 |
| Adam D. Levy | — | 04 Ağustos 2026 S | 66.008 | 1 | 1 | $13.221 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 başvurular | 23 Nisan 2026 | 28,80% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.